NCT05594485

Brief Summary

The purpose of this study is to describe the design, methodology and evaluation of the preclinical test of Carebot AI CXR software, and to provide evidence that the investigated medical device meets user requirements in accordance with its intended use. Carebot AI CXR is defined as a recommendation system (classification "prediction") based on computer-aided detection. The software can be used in a preclinical deployment at a selected site before interpretation (prioritization, display of all results and heatmaps) or after interpretation (verification of findings) of CXR images, and in accordance with the manufacturer's recommendations. Given this, a retrospective study is performed to test the clinical effectiveness on existing CXRs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
127

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 15, 2022

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 17, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2022

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

October 21, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 26, 2022

Completed
Last Updated

July 13, 2023

Status Verified

July 1, 2023

Enrollment Period

2 days

First QC Date

October 21, 2022

Last Update Submit

July 12, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Primary objective

    Comparison of the accuracy of radiologist and Carebot AI CXR image assessment.

    20-10-2022

Secondary Outcomes (1)

  • Secondary objective

    20-10-2022

Study Arms (1)

Retrospective collection of DICOM patient files for the period 15-17 August

To collect the CXR data for retrospective study, we addressed a municipal hospital in the Czech Republic that provides healthcare services to up to 130,000 residents of a medium-sized city (approximately 70,000 inhabitants) and the surrounding area. 127 anonymized CXR images were collected between August 15 and 17, 2022, and subsequently submitted to five independent radiologists of varying experience for annotation. The selected radiologists were asked to assess whether the CXR image shows any of the 12 abnormalities mentioned above. Pediatric CXR images (under 18 years of age), scans with technical problems (poor image quality, rotation), and images in lateral projection were excluded from the dataset.

Device: Carebot AI CXR

Interventions

Carebot AI CXR is a deep learning-based software that assists radiologists in the interpretation of chest radiographs in posterior-anterior (PA) or anterior-posterior (AP) projections. The solution with artificial intelligence automatically detects abnormality based on visual patterns for the following findings: atelectasis, consolidation, cardiomegaly, mediastinal widening, pneumoperitoneum, pneumothorax, pulmonary edema, pulmonary lesion, bone fracture, hilar enlargement, subcutaneous emphysema, and pleural effusion.

Retrospective collection of DICOM patient files for the period 15-17 August

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

To collect the CXR data for retrospective study, we addressed a municipal hospital in the Czech Republic that provides healthcare services to up to 130,000 residents of a medium-sized city (approximately 70,000 inhabitants) and the surrounding area. 127 anonymized CXR images were collected between August 15 and 17, 2022.

You may qualify if:

  • Hospital patients who were referred for chest radiography between August 15 and 17, 2022.

You may not qualify if:

  • Pediatric CXR images (under 18 years of age)
  • Scans with technical problems (poor image quality, rotation)
  • Images in lateral projection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nemocnice Havířov, p. o.

Havířov, 73601, Czechia

Location

MeSH Terms

Conditions

Lung DiseasesPneumothoraxPleural EffusionCardiomegalyLung NeoplasmsPulmonary EdemaPneumoniaPulmonary AtelectasisRib Fractures

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesPleural DiseasesHeart DiseasesCardiovascular DiseasesHypertrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsRespiratory Tract InfectionsInfectionsFractures, BoneWounds and InjuriesThoracic Injuries

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 21, 2022

First Posted

October 26, 2022

Study Start

August 15, 2022

Primary Completion

August 17, 2022

Study Completion

October 20, 2022

Last Updated

July 13, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

The results of the retrospective study are used to validate the Carebot AI CXR software for the target population prior to deployment in the workplace.

Locations